Imunon, Inc. — Director's Dealing 2016

Feb 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-02-02

Reporting Person: Anwer Khursheed (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-02	Option to Purchase Celsion Corporation Common Stock	$1.33	A	40000	Acquired	2026-02-02	Celsion Corporation Common Stock (40000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on February 2, 2016, February 2, 2017 and February 2, 2018.